A note from history: Landmarks in history of cancer, Part 6

Cancer

Volumn 119, Issue 23, 2013, Pages 4058-4082

  Hajdu, Steven I ^a   Vadmal, Manjunath ^b  

^a Los Angeles County University of Southern California Medical Center ^*

^b LAC USC MEDICAL CENTER   (United States)

Author keywords

history of cancer; history of cancer epidemiology and cancer institutions; history of cancer research; history of cytopathology; history of diagnostic radiology; history of immunology; history of medical oncology; history of radiation therapy; history of surgical oncology; history of surgical pathology

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; CANCER IMMUNOLOGY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER SURGERY; CAUSAL ATTRIBUTION; COMPUTER ASSISTED TOMOGRAPHY; CYTOPATHOLOGY; EXPERIMENTAL STUDY; FLUOROSCOPY; HISTORY OF MEDICINE; HUMAN; LABORATORY TEST; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TREND STUDY;

HISTORY OF CANCER; HISTORY OF CANCER EPIDEMIOLOGY AND CANCER INSTITUTIONS; HISTORY OF CANCER RESEARCH; HISTORY OF CYTOPATHOLOGY; HISTORY OF DIAGNOSTIC RADIOLOGY; HISTORY OF IMMUNOLOGY; HISTORY OF MEDICAL ONCOLOGY; HISTORY OF RADIATION THERAPY; HISTORY OF SURGICAL ONCOLOGY; HISTORY OF SURGICAL PATHOLOGY;

ANIMALS; HISTORY, 20TH CENTURY; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; UNITED STATES;

EID: 84887989967     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28319     Document Type: Article

References (332)

1. Hajdu SI,. A note from history: landmarks in history of cancer, part 4. Cancer. 2012; 118: 4914-4928.
2. Hajdu SI, Darvishian F,. A note from history: landmarks in history of cancer, part 5. Cancer. 2013; 119: 1450-1466.
3. Berenblum I,. The mechanism of carcinogenesis: a study of the significance of carcinogenic action and related phenomena. Cancer Res. 1941; 1: 807-814.
4. Friedenwald WF, Rous P,. The initiating and promoting elements in tumor production. An analysis of the effects of tar, benzpyrene, and methylcholanthrene on rabbit skin. J Exp Med. 1944; 80: 101-120.
5. Spitz S, Maguigan WH, Dobriner K,. The carcinogenic action of benzidine. Cancer. 1950; 3: 789-804.
6. Sunderland DA, Smith WE, Sugiura K,. The pathology and growth behavior of experimental tumors induced by certain petroleum products. Cancer. 1951; 4: 1232-1245.
7. Hartwell JL,. Survey of compounds which have been tested for carcinogenic activity. Washington, DC: National Cancer Institute; 1951.
8. Lancaster MC, Jenkins FP, Philip JM,. Toxicity associated with certain samples of groundnuts. Nature. 1961; 192: 1095-1096.
9. Druckrey H,., Preussmann R, Ivankovic S, Schmidt CH, Mennel HD, Stahl KW,. Selective enzengung vonBlasenkrebs an Ratten durch Dibutyl-und N-butanol nitrosamine. Z Krebsforsch. 1964; 66: 280-290.
10. Harrold KM,. Induction of olfactory neuroepithelial tumors in Syrian hamsters by diethylnitrosamine. Cancer. 1964; 17: 114-121.
11. Ghadially FN, Roy S,. Experimentally produced synovial sarcomas. Cancer. 1966; 19: 1901-1908.
12. Erturk E, Price JM, Morris JE, at al. The production of carcinoma of the urinary bladder in rats by feeding N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide. Cancer Res. 1967; 27: 1998-2002.
13. Cutts JH, Noble RL,. Estrone-induced mammary tumors in the rat. I: Induction and behavior of tumor. Cancer Res. 1969; 24: 1116-1123.
14. Claude A, Porter KR, Pickles EG,. Electron microscope study of chicken tumor cells. Cancer Res. 1947; 7: 421-430.
15. Gross L,. Spontaneous leukemia developing in C3H mice following inoculation, in infancy, with AK-leukemic extracts, or AK-embryos. Proc Soc Exp Biol Med. 1951; 67: 27-32.
16. Stewart SE,. Leukemia in mice produced by a filterable agent present in AKR leukemic tissues with notes on a sarcoma produced by the same agent. Anat Rev. 1953; 117: 532-536.
17. Holland JF, Frei E,. Cancer Medicine. Philadelphia, PA: Lea & Febiger; 1973.
18. Watson JD, Crick FHC,. Molecular structure of nucleic acids: structure for deoxyribose nucleic acid. Nature. 1953; 171: 737-738.
19. Vogt M, Dulbecco R,. Virus-cell interaction with a tumour-producing virus. Proc Natl Acad Sci U S A. 1960; 46: 365-370.
20. Huebner RJ, Todaro GJ,. Oncogenes of RNA tumor viruses as determinates of cancer. Proc Natl Acad Sci U S A. 1969; 64: 1087-1094.
21. Temin HM, Mizutani S,. RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature. 1970; 226: 1211-1213.
22. Baltimore D,. RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature. 1970; 226: 1209-1211.
23. Doll R,. Mortality from lung cancer in asbestos workers. Br J Ind Med. 1955; 12: 81-86.
24. March HC,. Leukemia in radiologists. Radiology. 1947; 43: 275-278.
25. Cahan WG, Woodward HQ, Higinbotham NL, et al. Sarcoma arising in irradiated bone. Report of eleven cases. Cancer. 1948; 1: 3-29.
26. Hill AB, Fanning EL,. Studies in the incidence of cancer in a factory handling inorganic compounds of arsenic. Br J Ind Med. 1948; 5: 1-6.
27. Acosta-Sison H,. Statistical study of choriocarcinoma in the Philippine General Hospital. Am J Obstet Gynecol. 1949; 58: 125-132.
28. Acheson ED, Cowdell RH, Hadfield E, et al. Nasal cancer in woodworkers in the furniture industry. Br Med J. 1968; 2: 587-596.
29. McClure JA, Higgins CC,. Bilateral carcinoma of male breast after estrogen therapy. JAMA. 1951; 146: 7-9.
30. Cole P, MacMahon B,. Oestrogen fractions during early reproductive life in the aetiology of breast cancer. Lancet. 1969; 1: 604-606.
31. Roffo AH,. Correlation del valor cancerigenic del alquitran del tobacco con el de hulla. Prensa Med Argent. 1941; 28: 1003.
32. Ochsner A, DeBakey M,. Carcinoma of the lung. Arch Surg. 1941; 22: 209-258.
33. Mills CA, Mills Porter M,. Tobacco smoking habits and cancer of the mouth and respiratory system. Cancer Res. 1950; 10: 539-542.
34. Wynder EL, Graham EA,. Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma. JAMA. 1950; 143: 329-336.
35. Doll R, Bradford Hill A,. Smoking and carcinoma of the lung. Br Med J. 1950; 2: 739-748.
36. Smoking and Health: Report of the Advisory Committee to the Surgeon General of Public Health Service. Public Health Service Publication No. 1103. Washington, DC: Department of Health, Education, and Welfare, Public Health Service; 1964.
37. Hajdu SI, Vadmal MS,. A note from history: The use of tobacco. Ann Clin Lab Sci. 2010; 40: 178-181.
38. Foote FW, Stewart FW,. Comparative studies of cancerous versus noncancerous breasts. Ann Surg. 1945; 121: 6-222.
39. MacMahon HE, Murphy AS, Bates MI,. Endothelial-cell sarcoma of liver following thorotrast injections. Am J Pathol. 1947; 23: 585-611.
40. Moss WT,. Common peculiarities of patients with adenocarcinoma of the endometrium, with special reference to obesity, body build, diabetes and hypertension. Am J Roentgenol Radium Ther Nucl Med. 1947; 58: 203-210.
41. Schrek L, Lenowitz H,. Etiologic factors in carcinoma of the penis. Cancer Res. 1947; 7: 180-184.
42. Hertig AT, Sheldon WH,. Hydatidiform mole: a pathologico-clinical correlation of 200 cases. Am J Obstet Gynecol. 1947; 53: 1-33.
43. Gusberg SB,. Precursors of corpus carcinoma, estrogens, and adenomatous hyperplasia. Am J Obstet Gynecol. 1947; 54: 905-927.
44. Ackerman LV, Del Regato JA,. Cancer. Diagnosis, Treatment and Prognosis. St. Louis, MO: C.V. Mosby; 1947.
45. Sunderland DA, Brinkley GE,. Papillary adenoma of the large intestine. A clinical morphological study of forty-eight cases. Cancer. 1948; 1: 184-207.
46. McAnally AK, Dockert MB,. Carcinoma developing in chronic draining cutaneous sinuses and fistulas. Surg Gynecol Obstet. 1949; 88: 87-97.
47. Morson BC,. Carcinoma arising from areas of intestinal metaplasia in the gastric mucosa. Br J Cancer. 1955; 9: 377-383.
48. Auerbach O, Gere JB, Forman JB, et al. Changes in the bronchial epithelium in relation to smoking and cancer of the lung. N Engl J Med. 1957; 256: 97-107.
49. Hou PC,. The relationship between primary carcinoma of the liver and infestation with Clonorchia sinensis. J Pathol Bacteriol. 1956; 72: 239-246.
50. Steiner PE,. Carcinoma of liver in the United States. Acta Unio Int Contra Cancrum. 1957; 13: 628-645.
51. Liszauer S, Ross RC,. Lymphangiosarcoma in lymphoedema. Can Med Assoc J. 1957; 76: 475-477.
52. Bartholomew LG, Gross JB, Comfort MW,. Carcinoma of the pancreas associated with chronic relapsing pancreatitis. Gastroenterology. 1958; 35: 473-481.
53. Burch GE, Ansari A,. Chronic alcoholism and carcinoma of the pancreas. Arch Intern Med. 1968; 122: 273-275.
54. Liavoag I,. Atrophy and regeneration in the pathogenesis of prostatic carcinoma. Acta Pathol Microbiol Scand. 1958; 73: 338-350.
55. Haenszel W, Hillhouse M,. Uterine-cancer morbidity in New York City and its relation to pattern of regional variation within the United States. J Natl Cancer Inst. 1959; 22: 1157-1181.
56. Embrey MP,. Vulvar carcinoma complicating condyloma acuminate. J Obstet Gynaec Br Emp. 1961; 68: 503-504.
57. Dahan I, Jonsson N, Lundh G,. Desmoid tumors: A series of 33 cases. Acta Chir Scand. 1963; 126: 305-314.
58. Oknyama K,. Primary liver cell carcinoma associated with biliary cirrhosis due to congenital bile duct atresia. J Pediatr. 1965; 67: 89-93.
59. Jernstrom P, Brewer LA,. Primary adenocarcinoma of the mid-esophagus arising in ectopic gastric mucosa with associated hiatal hernia and reflux esophagatis. Cancer. 1970; 26: 1134-1348.
60. Tokuhata GK, Lilienfeld AM,. Familial aggregation of lung cancer among hospital patients. Public Health Rep. 1963; 78: 277-283.
61. Lynch HT, Shaw MW, Magnuson CW, et al. Hereditary factors in two large midwestern kindreds. Arch Intern Med. 1966; 117: 206-212.
62. Anderson DE, Taylor WB, Falls HF, et al. The nevoid basal cell carcinoma syndrome. Am J Hum Genet. 1967; 19: 12-22.
63. Lynch HT,. Hereditary Factors in Carcinoma. Recent Results in Cancer Research. New York: Springer-Verlag; 1967.
64. Schimke RN, Hartman WH, Prout TE, et al. Syndrome of bilateral pheochromocytoma, medullary thyroid carcinoma and multiple neuromas. N Engl J Med. 1968; 279: 1-7.
65. Lewis ACW, Davison BCC,. Familial ovarian cancer. Lancet. 1969; 2: 235-237.
66. Lynch HT, Anderson DE, Krush AJ,. Heredity and intraocular malignant melanoma. Cancer. 1968; 21: 119-125.
67. Li FP, Fraumeni JF,. Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. J Natl Cancer Inst. 1969; 43: 1365-1373.
68. Gutman AB, Gutman EB,. An "acid" phosphatase occurring in the serum of patients with metastasizing carcinoma of the prostate gland. J Clin Invest. 1938; 17: 473-478.
69. Gomori G,. Distribution of acid phosphatase in the tissues under normal and under pathological conditions. Arch Pathol. 1941; 32: 189-199.
70. Longsworth LG, Shedlovsky T, Macinnes DA,. Electrophoretic patterns of normal and pathological human blood serum and plasma. J Exp Med. 1939; 70: 399-413.
71. Twombly GH, Temple HM, Dean AL,. Clinical value of the Aschheim-Zondek test in the diagnosis of testicular tumors. JAMA. 1942; 118: 106-111.
72. Johnson TA, Bockus HL,. The present status of the serum lipase test. Am J Digest Dis. 1943; 10: 1-7.
73. Gey GO, Coffman WD, Kubicek MT,. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res. 1952; 12: 264-265.
74. Sjoerdsma A, Weissbach H, Undenfriend S,. Simple test for diagnosis of metastatic carcinoid (Argentaffinoma). JAMA. 1955; 159: 397.
75. Delfs E,. Chorionic gonadotropin determinations in patients with hydatidiform mole and choriocarcinoma. Ann N Y Acad Sci. 1957; 80: 125-139.
76. Lambert EH, Eaton LM, Rooke ED,. Defect of neuromuscular conduction associated with malignant neoplasms. Am J Physiol. 1956; 187: 612-613.
77. Omland G,. Polycythemia in renal carcinoma. Acta Med Scand. 1959; 164: 451-454.
78. Novell PC, Hungerford DA,. A minute chromosome in human chronic granulocytic leukemia. Science. 1960; 132: 1197.
79. Abelev GI,. Antigenic structure of chemically induced hepatomas. Prog Exp Tumor Res. 1965; 7: 104-157.
80. Gold P, Freedman SO,. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med. 1965; 121: 439-462.
81. Thompson DMP, Krupey J, Freedman SO, et al. The radioimmunoassay of circulating carcinoebryonic antigen of the human digestive system. Proc Natl Acad Sci U S A. 1969; 64: 161-167.
82. Hajdu SI,. Cytology from antiquity to Papanicolaou. Acta Cytol. 1977; 21: 668-676.
83. Papanicolaou GN, Traut HF,. The diagnostic value of vaginal smears in carcinoma of the uterus. Am J Obstet Gynecol. 1941; 42: 193-206.
84. Papanicolaou GN, Traut HF,. Diagnosis of Uterine Cancer by the Vaginal Smear. New York: The Commonwealth Fund; 1943.
85. Papanicolaou GN,. Atlas of Exfoliative Cytology. Cambridge, MA: Harvard Univ Press; 1954.
86. Hajdu SI, Ehya H,. Foundation of diagnostic cytology. Ann Clin Lab Sci. 2008; 38: 296-299.
87. Erickson CC, Everett BE, Graves LM, et al. Population screening for uterine cancer by vaginal cytology. Preliminary summary of results of first examination of 108,000 women and second testing of 33,000 women. JAMA. 1956; 162: 167-173.
88. Christopherson WM, Parker JE, Drye J,. Control of cervical cancer. Preliminary report on community program. JAMA. 1962; 182: 179-182.
89. Gates O,., Warren SA,. Handbook for the Diagnosis of Cancer of the Uterus by the Use of Vaginal Smears. Cambridge, MA: Harvard Univ Press; 1947.
90. Ayre JE,. Cancer Cytology of the Uterus. London, UK: Churchill; 1952.
91. Hajdu SI,. Acta Cytologica 40 years ago. Dyscariosis. Acta Cytol. 1997; 41: 621-622.
92. Samuels ML, Old JW, Howe CD,. Needle biopsy of the pleura. An evaluation in patients with pleural effusion of neoplastic origin. Cancer. 1958; 11: 980-983.
93. Schajowicz F, Derqui JC,. Puncture biopsy in lesions of the locomotor system. Cancer. 1968; 21: 531-548.
94. Koss L,. Diagnostic Cytology and Its Histopathologic Bases. Philadelphia, PA: J.B. Lippincott; 1961.
95. Dalton AJ, Felix MD,. The electron microscopy of normal and malignant cells. Ann N Y Acad Sci. 1956; 63: 1117-1140.
96. Wied GL,. Definition, morphology, cytochemistry and diagnostic importance of dyskaryotic cells. Acta Cytol. 1957; 1: 23-61.
97. Mauer AM, Fisher V,. In vivo study of cell kinetics in acute leukemia. Nature. 1963; 197: 574-576.
98. Tolles WE, Bostrom RC,. Automatic screening of cytology smears for cancer: The instrumentation. Ann N Y Acad Sci. 1956; 63: 1211-1218.
99. Kamentsky LA, Derman H, Melamed MR,. Ultraviolet absorption of epidermoid cancer cells. Science. 1963; 142: 1580-1583.
100. Levan A,. Chromosome studies on some human tumors and tissues of normal origin, grown in vivo and in vitro at the Sloan-Kettering Institute. Cancer. 1956; 9: 657-661.
101. Atkin NB,. The relationship between the deoxyribonucleic acid content and ploidy of human tumors. Cytogenetics. 1962; 1: 113-122.
102. Ewing J,. Neoplastic Diseases. A Treatise on Tumors. Edition 4. Philadelphia, PA: W.B. Saunders; 1940.
103. Boyd W,. Surgical Pathology. Edition 6. Philadelphia, PA: W.B. Saunders; 1947.
104. Hajdu SI,. The first editor of Cancer and his contribution to oncology. Cancer. 2008; 113: 1718-1723.
105. Pollock RE,. The seminal role of Cancer in our understanding of sarcoma. Cancer. 2008; 113: 1969-1979.
106. Stout AP,. Human Cancer. Philadelphia, PA: Lea & Febiger; 1932.
107. Stout AP, Murray MR,. Hemangiopericytoma: A vascular tumor featuring Zimmerman's pericytes. Ann Surg. 1942; 116: 26-33.
108. Stout AP,. Mesenchymoma. The mixed tumor of mesenchymal derivatives. Ann Surg. 1948; 127: 278-290.
109. O'Brien JE, Stout AP,. Malignant fibrous xanthoma. Cancer. 1964; 17: 1445-1455.
110. Brinkley JS, Stewart FW,. Morphogenesis of extraskeletal osteogenic sarcoma and pseudo-osteosarcoma. Arch Pathol. 1940; 29: 42-56.
111. Foote FW, Stewart FW,. Lobular carcinoma in situ: a rare form of mammary cancer. Am J Pathol. 1941; 17: 491-496.
112. Hellwig CA,. Extramedullary plasma cell tumors as observed in various locations. Arch Pathol. 1943; 36: 95-111.
113. Herbut PA,. Bronchiolar origin of "alveolar cell tumor" of the lung. Am J Pathol. 1944; 20: 911-929.
114. Liebow AA,. Bronchiolo-alveolar carcinoma. Adv Intern Med. 1960; 10: 329-358.
115. Stewart FW, Foote FW, Becker WF,. Muco-epidermoid tumors of salivary glands. Ann Surg. 1945; 122: 820-844.
116. Foote FW, Frazell EL,. Tumors of the major salivary glands. Cancer. 1953; 6: 1065-1133.
117. Masson P,. Etude sur le seminome. Rev Can Biol. 1946; 5: 361-387.
118. Stewart FW, Treves N,. Lymphangiosarcoma in postmastectomy lymphedema. A report of six cases in elephantiasis chirurgica. Cancer. 1948; 1: 64-81.
119. Spitz S,. Melanomas of childhood. Am J Pathol. 1948; 24: 591-609.
120. Dameshek W,. Some speculation on the myeloproliferative syndromes. Blood. 1951; 1: 372-375.
121. Horn RC,. Carcinoma of the thyroid: description of a distinctive morphologic variant and report of seven cases. Cancer. 1951; 4: 697-707.
122. Kottmeier HI,. The classification and treatment of ovarian tumors. Acta Obstet Gynecol Scand. 1952; 31: 313-363.
123. Christopherson WM, Foote FW, Stewart FW,. Alveolar soft part sarcoma. Structurally characteristic tumor of uncertain histogenesis. Cancer. 1952; 5: 100-111.
124. Liebow AA,. Tumors of the Lower Respiratory Tract. Washington, DC: Armed Forces Institute of Pathology; 1952.
125. Lichtenstein L,. Histiocytosis X: Integration of eosinophilic granuloma of bone, Letterer-Siwe disease, and Schuller-Christian disease, as related manifestations of a single nosologic entity. Arch Pathol. 1953; 56: 84-102.
126. Allen AC, Spitz S,. Malignant melanoma. Cancer. 1953; 6: 1-45.
127. Thorson A, Biorck G, Bjorkman G, at al. Malignant carcinoid of the small intestine with metastases to the liver, valvular disease of the right side of the heart (pulmonary stenosis, and tricuspid regurgitation without septal defects), peripheral vasomotor symptoms, bronchoconstriction, and an unusual type of cyanosis. Am Heart J. 1954; 47: 795-817.
128. Fennell RH,. Carcinoma in situ of cervix with early invasive changes. Cancer. 1955; 8: 302-309.
129. Frick HC, Janonsky NA, Gusberg SB, et al. Early invasive cancer of the cervix. Am J Obstet Gynecol. 1963; 85: 926-939.
130. Masson P,. Tumeurs Humaines. Paris, France: Maloine; 1956.
131. Riopelle MD, Theriault JP,. Le rhabdomyosarcome alveolaire. Ann Anat Pathol. 1956; 1: 88-111.
132. Burkitt D,. Sarcoma involving jaws in African children. Br J Surg. 1958; 46: 218-223.
133. Epstein MA, Achong BG, Barr YM,. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet. 1964; 1: 702-703.
134. Golomb H,. "Hairy" cell leukemia: an unusual lymphoproliferative disease. Cancer. 1958; 42: 946-949.
135. Lichtenstein L, Bernstein D,. Unusual benign and malignant chondroid tumors of bone. Cancer. 1959; 12: 1142-1157.
136. Teilum G,. Endodermal sinus tumors of the ovary and testis: comparative morphogenesis of the so-called mesonephroma ovarii (Schiller) and extra-embryonic (yolk sac-allantoic) structures of the rat's placenta. Cancer. 1959; 12: 1092-1104.
137. Gould EA, Winship T, Philbin PH, et al. Observation on a "sentinel node" in cancer of the parotid. Cancer. 1960; 13: 77-78.
138. Moertel CG, Dockerty MB, Baggenstoss AH,. Multiple primary malignant neoplasms. I. Introduction and presentation of data. Cancer. 1961; 14: 221-230.
139. Dahlin DC, Henderson ED,. Mesenchymal chondrosarcoma: Further observation on a new entity. Cancer. 1962; 15: 410-417.
140. Miller RW, Fraumeni JF, Manning MD,. Association of Wilms' tumor with aniridia, hemihypertrophy and other congenital malformations. N Engl J Med. 1964; 270: 922-927.
141. Jensen EV, DeSombre ER, Jungblut PW,. Estrogen receptors in hormone responsive tissues and tumors. In:, Wissler RW, Dao TL, Wood S, editors. Endogenous Factors Influencing Host-Tumor Balance. Chicago, IL: University of Chicago Press; 1967.
142. Bensch KG, Corrin B, Pariente R, et al. Oat-cell carcinoma of the lung: its origin and relationship to bronchial carcinoid. Cancer. 1968; 22: 1163-1172.
143. Berg JW, Hajdu SI, Foote FW,. The prevalence of latent cancers in cancer patients. Arch Pathol. 1971; 91: 183-186.
144. Dabska M,. Malignant endovascular papillary angioendothelioma of the skin in childhood. Cancer. 1969; 24: 503-510.
145. Enzinger FM,. Epithelioid sarcoma: a sarcoma simulating a granuloma. Cancer. 1970; 26: 1029-1041.
146. Herbst AL, Scully RE,. Adenocarcinoma of the vagina in adolescence. A report of 7 cases including 6 clear cell carcinoma (so-called mesonephromas). Cancer. 1970; 25: 745-757.
147. Herbst AL, Ulfelder H, Poskanzer DC,. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med. 1971; 284: 878-881.
148. Jackson H, Parker F,. Hodgkin's disease. II. Pathology. N Engl J Med. 1944; 231: 35-44.
149. Rappaport H, Winter WJ, Hicks ER,. Follicular lymphoma. A reevaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases. Cancer. 1956; 9: 792-821.
150. Lukes RJ, Butler JJ,. The pathology and nomenclature of Hodgkin's disease. Cancer Res. 1966; 26: 1063-1083.
151. Jewett HJ, Strong GH,. Infiltrating carcinoma of the bladder: relation of depth of penetration of the bladder wall to incidence of local extension and metastases. J Urol. 1946; 55: 366-372.
152. Foote FW, Stewart FW,. A histologic classification of carcinoma of the breast. Surgery. 1946; 19: 74-99.
153. Bloom HJ, Richardson WW,. Histologic grading and prognosis in breast cancer. A study of 1049 cases of which 359 have been followed for 15 years. Br J Cancer. 1957; 11: 359-377.
154. Manual of Tumor Nomenclature and Coding. New York, NY: American Cancer Society; 1968.
155. Breslow A,. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970; 172: 902-908.
156. Henry RS,. The Armed Forces Institute of Pathology. Its First Century, 1862-1962. Washington, DC: Government Printing Office; 1964.
157. Firminger HI,. Atlas of Tumor Pathology Index. Washington, DC: Armed Forces Institute of Pathology; 1968.
158. Ackerman LV,. Surgical Pathology. St. Louis, MO: C.V. Mosby; 1953.
159. Chamberlain WE,. Fluoroscopes and fluoroscopy. Radiology. 1942; 38: 383-412.
160. Lima PA,. Cerebral Angiography. London, UK: Oxford University Press; 1950.
161. Kinmonth JB,. Lymphangiography in man. A method of outlining lymphatic trunks at operation. Clin Sci. 1952; 11: 13-20.
162. Nordenstrom B,. A new technique for transthoracic biopsy of lung changes. Br J Radiol. 1965; 38: 550-553.
163. Chiappa S, Uslenghi C, Galli G,. Lyphangiography and endolymphatic radiotherapy in testicular tumours. Br J Radiol. 1966; 39: 498-512.
164. Averette HE, Ravel R,. Lymphography with chlorophyll: effects on pelvic lymphadenectomy and lymph nodes. Obstet Gynecol. 1968; 37: 247-264.
165. Liebow AA,. Pathology of carcinoma of the lung as related to the roentgen shadow. Am J Roentgenol Radium Ther Nucl Med. 1955; 74: 383-401.
166. Pendergrass EP, Lafferty JO, Horn RC,. Osteogenic sarcoma and chondrosarcoma; with special reference to the roentgen diagnosis. Am J Roentgenol. 1945; 54: 234-256.
167. Dahlin DC,. Bone Tumors. General Aspects and Analysis of 2,276 Cases. Springfield, IL: C.C. Thomas; 1957.
168. Egan RL,. Experience with mammography in a tumor institution. Radiology. 1960; 75: 894-900.
169. Gershon-Cohen J, Hermel MB, Berger SM,. Detection of breast cancer by periodic x-ray examinations. A five-year survey. JAMA. 1961; 176: 1114-1116.
170. Strax P, Venet L, Shapiro S, et al. Mammography and clinical examination in mass screening for cancer of the breast. Cancer. 1967; 20: 2184-2188.
171. Shapiro S, Strax P, Venet L,. Periodic breast cancer screening in reducing mortality from breast cancer. JAMA. 1971; 215: 1777-1785.
172. Hylander GB,. Mammography: aid in detection of breast cancer. J Am Osteopath Assoc. 1969; 68: 457-468.
173. Hutter RV, Snyder RE, Lucas JC, et al. Clinical and pathologic correlation with mammographic findings in lobular carcinoma in situ. Cancer. 1969; 23: 826-839.
174. Donald I, MacVicar J, Brown TG,. Investigation of abdominal masses by pulsed ultrasound. Lancet. 1958; 1: 1188-1194.
175. Wild JJ, Reid JM,. Further pilot echographic studies on the histologic structure of tumors of the living intact human breast. Am J Pathol. 1952; 28: 839-861.
176. Howry DM, Scott DA, Bliss WR,. The ultrasonic visualization of carcinoma of the breast and other soft tissue structures. Cancer. 1954; 7: 354-358.
177. 131in thyroid cancer shown by radioautography. A study of 100 consecutive cases showing the relation of histological structure to the function of thyroid carcinoma. Cancer. 1950; 3: 86-105.
178. Frantz VK, Larsen WG, Jaretzki A,. The evaluation of radioactive iodine therapy in metastatic thyroid cancer. J Clin Endocrinol. 1950; 10: 1084-1091.
179. Brownell GL, Sweet WH,. Localization of brain tumors with positron emitters. Nucleonics. 1953; 11: 40-45.
180. Charkes ND, Sklaroff DM,. The radioactive strontium photoscan as a diagnostic aid in primary and metastatic cancer in bone. Radiol Clin N Am. 1965; 3: 499-509.
181. Morris JG, Coorey GJ, Dick R, et al. The diagnosis of renal tumors by radioisotope scanning. J Urol. 1967; 97: 40-54.
182. Kuhl DE, Edwards RQ,. Image separation radioisotope scanning. Radiology. 1966; 87: 278-284.
183. Hounsfield GN,. Computerized transverse axial scanning (tomography). Br J Radiol. 1973; 46: 1016-1022.
184. Berman L, Axelrod AR,. Effect of urethane on malignant diseases: Clinical, hematologic and histologic observations on patients with carcinoma, leukemia and related diseases. Am J Clin Pathol. 1948; 18: 104-126.
185. Holland JF, Hosley H, Scharlau C, et al. A controlled trial of urethane treatment in myeloma. Blood. 1966; 27: 328-342.
186. Alexander SF,. Medical report of the Bari Harbor mustard casualties. Mil Surg. 1947; 101: 2-17.
187. Goodman LS, Wintrobe MM, Dameshek W, et al. Nitrogen mustard therapy: use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris (beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia, and certain allied and miscellaneous disorders. JAMA. 1946; 132: 126-132.
188. Jacobson LO, Spurr CL, Barron ESG, et al. Nitrogen mustard therapy. Studies on the effect of methyl-bis (beta-chloroethyl) amine hydrochloride on neoplastic diseases and allied disorders of the hematopoietic system. JAMA. 1946; 132: 263-271.
189. Reinhard EH, Good JT, Martin E,. Chemotherapy of malignant neoplastic disease. JAMA. 1950; 142: 383-390.
190. Karnofsky DA, Abelman WH, Craver LF, et al. The use of the nitrogen mustards in the palliative treatment of cancer. Cancer. 1948; 1: 634-656.
191. Farber S, Diamond LK, Mercer RD, et al. Temporary remission in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl- glutaminic acid (aminopterin). N Engl J Med. 1948; 238: 787-793.
192. Farber S,. Carcinolytic action of antibiotics: puromycin and actinomycin D. Am J Pathol. 1955; 31: 582.
193. Farber S, D'Angio GJ, Evans A, et al. Clinical studies on actinomycin D with special reference to Wilms' tumor in children. Ann N Y Acad Sci. 1960; 89: 421-425.
194. Huggins CB, Hodges CV,. Studies of prostatic cancer. I. The effect of castration, of estrogen, and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res. 1941; 1: 293-297.
195. Pearson OH, Eliel LP,. Use of pituitary adrenocorticotropic hormone (ACTH) and cortisone in lymphomas and leukemias. JAMA. 1950; 144: 1349-1353.
196. Bernard J, Marie J, Salet J, et al. Essai de traitement des leucemies aigues de l'enfance par l'association aminopterin-cortison. Bull Mem Soc Med Hopitaux. 1951; 16: 621-625.
197. Galton DAG,. Myleran in chronic myeloid leukemia-Results of treatment. Lancet. 1953; 1: 208-213.
198. Burchenal JH, Murphy ML, Ellison RR, et al. Clinical evaluation of a new antimetabolite, 6-mercaptopurine, in the treatment of leukemia and allied diseases. Blood. 1953; 8: 965-999.
199. Li MC, Hertz R, Spencer DB,. Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma. Proc Soc Exp Biol Med. 1956; 93: 361-366.
200. Ultman JE, Hyman GA, Gellhorn A,. Chlorambucil in treatment of chronic lymphocytic leukemia and certain lymphomas. JAMA. 1956; 162: 178-183.
201. Heidelberger C, Chanduri NK, Danneberg P, et al. Fluorinated pyrimidines, a new class of tumor-inhibitory compounds. Nature. 1957; 179: 663-666.
202. Whiteside JA, Philips FS, Dargeon HW, Burchenal JH,. Intrathecal amethopterin in neurological manifestations of leukemia. AMA Arch Intern Med. 1958; 101: 279-285.
203. Noble RL, Beer CT, Cutts JH,. Role of chance observation in chemotherapy: Vinca rosea. Ann N Y Acad Sci. 1958; 76: 882-894.
204. Coggins PR, Ravdin RG, Eisman SH,. Clinical pharmacology and preliminary evaluation of cytoxan (cyclophosphamide). Cancer Chemother Rep. 1959; 3: 9-11.
205. Rudles RW, Grizzle J, Bell WN, et al. Comparison of chlorambucil and myleran in chronic lymphocytic and granulocytic leukemia. Am J Med. 1959; 27: 424-432.
206. Li MC, Whitmore WF, Golbey R, et al. Effects of combined drug therapy on metastatic cancer of the testis. JAMA. 1960; 174: 1291-1299.
207. Surgical Adjuvant Chemotherapy Breast Group: Breast adjuvant chemotherapy-Effectiveness of Thio-TEPA (triethylene thiophosphoramide) as adjuvant to radical mastectomy for breast cancer. Ann Surg. 1961; 154: 629-647.
208. Jones HC, Swinney J,. Thio-tepa in the treatment of tumors of the bladder. Lancet. 1961; 2: 615-618.
209. Rundles RW, Laszlo J, Garrison FE, et al. The antitumor spectrum of cyclophosphamide. Cancer Chemother Rep. 1962; 16: 407-411.
210. Sutow WW, Sullivan MP,. Cyclophosphamide therapy in children with Ewing's sarcoma. Cancer Chemother Rep. 1962; 23: 55-60.
211. Korst DR, Clifford GO, Fowler WM, et al. Multiple myeloma. Analysis of cyclophosphamide therapy in 165 patients. JAMA. 1964; 189: 758-762.
212. Dubost M, Ganter P, Maral R, et al. Une nouvel antibiotic a proprieties antitumorales. C R Hebd Seances Acad Sci. 1963; 257: 1813-1818.
213. Freireich EJ, Karon M, Frei E,. Quadruple combination therapy (VAMP) for acute lymphoblastic leukemia of childhood. Proc Am Assoc Cancer Res. 1964; 5: 20.
214. Frei E, Karon M, Levin RH, et al. The effectiveness of combinations of antileukemic agents in inducing and maintaining remission in children with acute leukemia. Blood. 1965; 26: 642-656.
215. Karon M, Freireich EJ, Frei E, et al. The role of vincristine in the treatment of childhood leukemia. Clin Pharmacol Ther. 1966; 7: 332-339.
216. Sutow WW,. Vincristine therapy for malignant solid tumors in children (except Wilms' tumor). Cancer Chemother Rep. 1968; 52: 485-487.
217. Goldin A, Vendetti JM, Kline I, et al. Eradication of leukemic cells by methotrexate and methotrexate plus citrovorum factor. Nature. 1966; 212: 1548-1550.
218. Umezawa H, Ishizuka M, Maeda K, et al. Studies on bleomycin. Cancer. 1967; 21: 891-895.
219. Hill JM, Roberts J, Loeb E, et al. L-Asparaginase therapy for leukemia and other malignant neoplasms. JAMA. 1967; 202: 882-888.
220. Tan C, Tosaka H, You K-P, et al. Daunomycin, an antitumor antibiotic in the treatment of neoplastic disease. Cancer. 1967; 20: 333-353.
221. George P, Hernandez K, Hustu O, et al. A study of "total therapy" of acute lymphocytic leukemia in children. J Pediatr. 1968; 72: 399-408.
222. Carbone PP, Spurr C, Schneiderman M, et al. Management of patients with malignant lymphoma, a comparative study with cyclophosphamide and vinca alkaloids. Cancer Res. 1968; 28: 811-822.
223. Boiron M,. Daunorubicin in the treatment of acute myelocytic leukemia. Lancet. 1969; 1: 330-333.
224. Rosenberg B, Van Camp L, Trosko JE, et al. Platinum compounds: a new class of potent antitumor agents. Nature. 1969; 222: 385-386.
225. Di Marco A, Gaetani M, Scarpinato B,. Adriamycin (NSC-123, 127): a new antibiotic with antitumor activity. Cancer Chemother Rep. 1969; 53: 33-37.
226. Alexaniaan R, Haut A, Khan AU, et al. Treatment for multiple myeloma: combination chemotherapy with different Melphalan doses regimens. JAMA. 1969; 208: 1680-1685.
227. DeVita VT, Moxley JH, Brace K, et al. Intensive combination chemotherapy and x-irradiation in the treatment of Hodgkin's disease. Proc Am Assoc Cancer Res. 1965; 6: 15.
228. DeVita VT, Serpick AA, Carbone PP,. Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med. 1970; 73: 881-895.
229. Lowenbraun S, DeVita VT, Serpick AA,. Combination chemotherapy with nitrogen mustard, vincristine, procarbazine, and prednisone in lymphosarcoma and reticulum cell sarcoma. Cancer. 1970; 25: 1018-1025.
230. Fisher B, Ravdin RG, Ausman RK, et al. Surgical adjuvant chemotherapy in cancer of the breast: Results of a decade of cooperative investigation. Ann Surg. 1968; 168: 337-356.
231. Li MC,. Fluorouracil as an adjuvant to colorectal cancer surgery. JAMA. 1977; 237: 872.
232. Desjardins AU,. Salient factors in the treatment of Hodgkin's disease and lymphosarcoma with roentgen rays. Am J Roentgenol. 1945; 54: 707-722.
233. Jones HW, Jones GES,. Panhysterectomy versus irradiation for early cancer of the uterine cervix. JAMA. 1943; 122: 930-932.
234. Heyman J, Benner S,. Further experience with radiotherapy in cancer of the corpus of the uterus. Acta Radiol. 1946; 27: 328-333.
235. Buschke F, Cantril ST,. Roentgentherapy of carcinoma of the urinary bladder: An analysis of 52 patients treated with 800 K.V. roentgentherapy. J Urol. 1942; 48: 368-383.
236. Bacleese FL,. Roentgen therapy as the sole method of treatment of cancer of the breast. Am J Roentgen Rad Ther Nucl Med. 1949; 62: 311-319.
237. McWhirter R,. Treatment of cancer of breast by simple mastectomy and roentgenotherapy. Arch Surg. 1949; 59: 830-842.
238. Reese AB, Merriam GR, Martin HE,. Treatment of bilateral retinoblastoma by irradiation and surgery. Report on 15 year results. Am J Ophthalmol. 1949; 32: 175-190.
239. Henschke UK,. "Afterloading" application for radiation therapy of carcinoma of the uterus. Radiology. 1960; 74: 834.
240. Walstram R,. Remote-controlled afterloading radiotherapy apparatus. Phys Med Biol. 1965; 7: 225-228.
241. Peters MV,. A study of survival in Hodgkin's disease treated radiologically. Am J Roentgenol. 1950; 63: 299-311.
242. Rosenberg SA, Diamond HD, Craver LF,. Lymphosarcoma: the effects of therapy and survival in 1,269 patients in a review of 30 years experience. Ann Intern Med. 1960; 53: 877-897.
243. Gross RE, Neuhauser EBD,. Treatment of mixed tumors of the kidney in childhood. Pediatrics. 1950; 6: 843-852.
244. Martin CL,. Treatment of cancer of the tongue and its cervical metastasis with irradiation. South Med J. 1954; 47: 1-9.
245. Buschke F, Cantril ST,. Results of supervoltage roentgen therapy of esophageal carcinoma. J Thoracic Surg. 1953; 26: 105-108.
246. Rutledge F, Fletcher GH,. Transperitoneal pelvic lymphadenectomy following supervoltage irradiation for squamous cell carcinoma of the cervix. Am J Obstet Gynecol. 1958; 76: 321-334.
247. Pochin EE,. Prospects from the treatment of thyroid carcinoma with radioiodine. Clin Radiol. 1967; 18: 113-125.
248. Kaplan HS,. The role of intensive radiotherapy in the management of Hodgkin's disease. Cancer. 1966; 19: 356-367.
249. Page V, Gardner A, Karzmark CJ,. Physical and dosimetric aspects of the radiotherapy of malignant lymphomas. II. The inverted-Y technique. Radiology. 1970; 96: 619-626.
250. Sullivan MP, Vietti TJ, Fernbach DJ, et al. Clinical investigations in the treatment of meningeal leukemia: Radiation therapy regimens vs. conventional intrathecal methotrexate. Blood. 1969; 34: 301-319.
251. Johnson RE,. Total body irradiation of chronic lymphocytic leukemia: Incidence and duration of remission. Cancer. 1970; 25: 523-530.
252. Munnell EW,. The changing prognosis and treatment in cancer of the ovary: a report of 235 patients with primary ovarian cancer, 1952-1961. Am J Obstet Gynecol. 1968; 100: 790-805.
253. Perry H, Chu FC,. Radiation therapy in the palliative management of soft tissue sarcomas. Cancer. 1962; 15: 179-183.
254. McNeer GP, Cantin J, Chu FC, et al. Effectiveness of radiation therapy in the management of sarcoma of the soft somatic tissues. Cancer. 1968; 22: 391-397.
255. Phillips RE, Higinbotham NL,. The curability of Ewing's endothelioma of bone in children. J Pediatr. 1967; 70: 391-397.
256. Strong EW, Henschke UK, Nickson JJ, et al. Preoperative x-ray therapy as an adjunct to radical neck dissection. Cancer. 1966; 19: 1509-1516.
257. Fisher B, Slack NH, Cavanough PJ, et al. Postoperative radiotherapy in the treatment of breast cancer: results of the NSABP No. 2 clinical trial. Ann Surg. 1970; 172: 711-732.
258. March HC,. Leukemia in radiologists. Radiology. 1944; 43: 275-278.
259. Hatcher CH,. The development of sarcoma in bone subjected to Roentgen or radium irradiation. J Bone Joint Surg. 1945; 27: 179-195.
260. Duffy BJ, Fitzgerald PJ,. Thyroid cancer in childhood and adolescence. Cancer. 1950; 3: 1018-1032.
261. Block MA, Miller MJ, Horn RC,. Carcinoma of the thyroid after external radiation to the neck in adults. Am J Surg. 1969; 118: 764-769.
262. Auerbach O, Friedman M, Weiss L, et al. Extraskeletal osteogenic sarcoma arising in irradiated tissue. Cancer. 1951; 4: 1095-1106.
263. Oberman HA, Oneal RM,. Fibrosarcoma of the chest wall following resection and irradiation of carcinoma of the breast. Am J Clin Pathol. 1970; 53: 407-412.
264. Socolow EL, Hashizume A, Neriishi S, et al. Thyroid carcinoma in man after exposure to ionizing radiation. A summary of the findings in Hiroshima and Nagasaki. N Engl J Med. 1968; 268; 406-410.
265. Hajdu SI,. A note from history: Landmarks in history of cancer, part 1. Cancer. 2011; 117: 1097-1102.
266. Hajdu SI,. A note from history: Landmarks in history of cancer, part 2. Cancer. 2011; 117: 2811-2820.
267. Hajdu SI,. A note from history: Landmarks in history of cancer, part 3. Cancer. 2012; 118: 1155-1168.
268. Morton JJ,. Interinnomino-abdominal (hindquarter) amputation. Ann Surg. 1942; 115: 628-646.
269. Belt E,. Radical perineal prostatectomy in early carcinoma of the prostate. J Urol. 1942; 48: 287-297.
270. Young HH,. The cure of cancer of the prostate by radical perineal prostatectomy (Prostato-seminal vesiculectomy). J Urol. 1945; 53: 188-252.
271. Pack GT, Scharnagel I, Morfit M,. Principle of excision and dissection in continuity for primary and metastatic melanoma of skin. Surgery. 1945; 17: 849-866.
272. Brunschwig A,. Complete excision of pelvic viscera for advanced carcinoma: A one step abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy. Cancer. 1948; 1: 177-186.
273. Brunschwig A, Daniel W,. The surgical treatment of cancer of the cervix uteri. Am J Obstet Gynecol. 1958; 75: 875-881.
274. Lewis LG,. Radioresistant testis tumors: results in 133 cases; five-year follow-up. J Urol. 1953; 69: 841-844.
275. Patey DH, Dyson WH,. Prognosis of carcinoma of the breast in relation to type of operation performed. Br J Cancer. 1948; 2: 7-12.
276. Dahl-Iversen E, Sverensen G,. Recherches sur les metastases microscopique des ganglions lymphatiques parasternaux dans le cancer du sein. J Int Chir Thorax. 1951; 11: 492-509.
277. Urban JA,. Radical excision of the chest wall for mammary cancer. Cancer. 1951; 4: 1263-1285.
278. Sweet RH,. The results of radical surgical extirpation in the treatment of carcinoma of the esophagus and cardia. With five year survival statistics. Surg Gynecol Obstet. 1952; 94: 46-52.
279. Whitmore WF, Marshall VF,. Radical total cystectomy for cancer of the bladder: 230 consecutive cases five years later. J Urol. 1962; 87: 853-868.
280. Henderson ED, Dahlin DC,. Chondrosarcoma of bone. A study of two hundred and eighty-eight cases. J Bone Joint Surg Am. 1963; 45: 1450-1458.
281. Miller TR, MacKenzie AR, Randall HT,. Translumbar amputation for advanced cancer: indications and physiologic alterations in four cases. Ann Surg. 1966; 164: 514-521.
282. Auchincloss H,. Significance of location and number of axillary metastases in carcinoma of the breast. Ann Surg. 1963; 159: 37-46.
283. Peters MV,. Wedge resection and irradiation as effective treatment in early breast cancer. JAMA. 1967; 200: 144-145.
284. Handley RS, Thackray AC,. Conservative radical mastectomy (Patey's operation). Ann Surg. 1969; 170: 880-882.
285. Coventry MB, Dahlin DC,. Osteogenic sarcoma: a critical analysis of 430 cases. J Bone Joint Surg Am. 1957; 39: 741-758.
286. Bowden L, Booher RJ,. The principles and technique of resection of soft parts for sarcoma. Surgery. 1958; 44: 963-977.
287. Peterson O,. Spontaneous course of cervical precancerous condition. Am J Obstet Gynecol. 1956; 72: 1063-1071.
288. Hajdu SI, Adelman HC,. Anatomic distribution and grading of carcinoma in situ of the cervix. Cancer. 1966; 19: 1466-1472.
289. Adelman HC, Hajdu SI,. Role of conization in the treatment of cervical carcinoma in situ. Am J Obstet Gynecol. 1967; 98: 173-179.
290. Frachia AA, Farrow JH, DePalo AJ, et al. Castration for primary inoperable or recurrent breast carcinoma. Surg Gynecol Obstet. 1969; 128: 1226-1234.
291. Mohs FE,. Chemosurgery, a microscopically controlled method of cancer excision. Arch Surg. 1941; 42: 279-295.
292. Alexander J, Haight C,. Pulmonary resection for solitary metastatic sarcomas and carcinomas. Surg Gynecol Obstet. 1947; 85: 129-146.
293. Woodington GF, Waugh JM,. Results of resection of metastatic tumors of the liver. Am J Surg. 1963; 105: 24-29.
294. Starzl TE, Marchioro TL, von Kaulla KN, et al. Homotransplantation of the liver in humans. Surg Gynecol Obstet. 1963; 117: 659-676.
295. Gilchrist RK, Merricks JW, Hamlin HH, et al. Construction of a substitute bladder and urethra. Surg Gynecol Obstet. 1950; 90: 752-760.
296. Nichols JA, Marshall VF,. The treatment of bladder carcinoma by local excision and fulguration. Cancer. 1956; 9: 559-565.
297. Wangensteen OH, Lewis FJ, Tongen LA,. The "second-look" in cancer surgery: a patient with colic cancer and involved lymph nodes negative on the "sixth-look." Lancet. 1951; 71: 303-307.
298. Gilbertson VA, Wagensteen OH,. A summary of thirteen years' experience with the second look program. Surg Gynecol Obstet. 1962; 114: 438-442.
299. Hirschcowitz BI,. Demonstration of the new gastroscope, the "fiberscope". Gastroenterology. 1958; 35: 50-53.
300. Sykes MP, Karnofsky DA, McNeer GP, et al. Splenectomy in far-advanced Hodgkin's disease. Report of five cases. Blood. 1954; 9: 824-836.
301. Semm K,. Die laparoscopie in der Gynecologie. J Geburtshilfe Frauenheilkd. 1967; 27: 1029-1034.
302. Averette HE, Leplatney DR, Little WA,. Current role of radical hysterectomy as primary therapy for invasive carcinoma of the cervix. Am J Obstet Gynecol. 1969; 105: 79-89.
303. Gross L,. Intradermal immunization of C3H mice against a sarcoma that originated in an animal of the same line. Cancer Res. 1943; 3: 326-333.
304. Foley EJ,. Antigenic properties of methylcholanthrene induced tumors in mice of the strain of origin. Cancer Res. 1953; 13: 835-837.
305. Old LJ, Boyse EA, Clarke DA, et al. Antigenic properties of chemically induced tumors. Ann N Y Acad Sci. 1962; 101: 80-106.
306. Gold P, Freedman SO,. Specific carcinoembryonic antigens of the human digestive system. J Exp Med. 1965; 122: 467-481.
307. Klein G, Klein E, Clifford P,. Search for host defenses in Burkitt lymphoma: membrane immunofluorescence tests on biopsies and tissue culture lines. Cancer Res. 1967; 27: 2510-2520.
308. Morton DL, Malmgren RA, Holmes EC, et al. Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery. 1970; 68: 158-164.
309. Graham JB, Graham RM,. Autogenous vaccine in cancer patients. Surg Gynecol Obstet. 1962; 114: 1-4.
310. Cunningham TJ, Olson KB, Laffin R, et al. Treatment of advanced cancer with active immunization. Cancer. 1969; 24: 932-937.
311. Murray G,. Experiments in immunity in cancer. Can Med Assoc J. 1958; 79: 249-259.
312. Laszlo J, Buckley CE, Amos DB,. Infusion of isologous immune plasma in chronic lymphocytic leukaemia. Blood. 1968; 31: 104-110.
313. Mathe G,. Active immunotherapy for acute lymphoblastic leukaemia. Lancet. 1969; 1: 697-699.
314. Nadler SH, Moore GE,. Immunotherapy of malignant disease. Arch Surg. 1969; 99: 376-381.
315. Woodruff MFA, Nolan B,. Preliminary observations on treatment of advanced cancer by injection of allogeneic spleen cells. Lancet. 1963; 2: 426-429.
316. Dausset J,. Iso-leuco-anticops. Acta Haemat. 1958; 20: 156-166.
317. Thomas ED, Lochte HL, Lu WC, et al. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med. 1957; 257: 491-496.
318. Good RA, Finstad J,. Essential relationship between the lymphoid system, immunity, and malignancy. Natl Cancer Inst Monogr. 1969; 31: 41-58.
319. Gerson RK, Kondo K,. Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology. 1970; 18: 723-737.
320. Good RA, Dalmasso AP, Martinez C, et al. The role of the thymus in development of immunologic capacity in rabbits and mice. J Exp Med. 1962; 116: 773-796.
321. Coons AH, Creech HJ, Jones RN,. Immunologic properties of an antibody containing a fluorescent group. Proc Soc Exp Biol Med. 1941; 47: 200-202.
322. Hara M, Inoue T, Koyanagi Y, et al. Immunochemical characteristics of human specific component "gamma-sm". Nippon Hoigaku Zasshi. 1969; 23: 333.
323. Henle G, Henle W, Cliford P, et al. Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. J Natl Cancer Inst. 1969; 43: 1147-1157.
324. Harris JE, Sinkovics JG,. The Immunology of Malignant Disease. St. Louis, MO: C.V. Mosby; 1970.
325. Shimkin MB,. Contrary to Nature. Washington, DC: US Department of Health; 1976.
326. Rusch HP,. The beginnings of cancer research centers in the United States. J Natl Cancer Inst. 1985; 74: 391-403.
327. Fleming I, Eyre H, Pogue J,. The American Cancer Society. A History of Saving Lives. Atlanta, GA: American Cancer Society; 2010.
328. Gansler T, Ganz PA, Grant M, et al. Sixty years of CA: A Cancer Journal for Clinicians. CA Cancer J Clin. 2010; 60: 345-350.
329. Denoix PF,. Concerning the "diversity" of certain cancers: based on 33,784 observations on cancers of the breast, cervix uteri, tongue, skin, larynx, oesophagus and rectum. French Ministry of Public Health National Institute of Hygiene Monograph 4. Paris, France; 1954.
330. Dorn HF, Cutler SJ,. Morbidity From Cancer in the United States. Washington, DC: US Department of Health; 1955.
331. US Public Health Service Publication 1113. Death Rates for Malignant Neoplasms. Cancer Control Program. Washington, DC: US Government Printing Office; 1964.
332. Devesa SS, Silverman DT,. Cancer incidence and mortality trends in the United States: 1935-74. J Natl Cancer Inst. 1978; 60: 545-571.